Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy

Leukemia. 2020 Jun;34(6):1684-1688. doi: 10.1038/s41375-019-0688-1. Epub 2019 Dec 16.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Clonal Evolution / drug effects*
  • Clonal Evolution / genetics
  • Female
  • Humans
  • Leukemia, Neutrophilic, Chronic / drug therapy*
  • Leukemia, Neutrophilic, Chronic / genetics*
  • Male
  • Mutation
  • Nitriles
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles / therapeutic use*
  • Pyrimidines

Substances

  • Antineoplastic Agents
  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib